tiprankstipranks
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market
1952
Everest Medicines Ltd.
RESEARCH TOOLSreports

Everest Medicines Ltd. (1952) Income Statement

4 Followers

Everest Medicines Ltd. Income Statement

Last quarter (Q2 2025), Everest Medicines Ltd.'s total revenue was ¥223.06M, an increase of 47.96% from the same quarter last year. In Q2, Everest Medicines Ltd.'s net income was ¥-124.89M. See Everest Medicines Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.66B¥ 706.68M¥ 125.93M¥ 12.79M¥ 54.00K
Gross Profit
¥ 998.84M¥ 528.89M¥ 91.52M¥ 8.15M¥ 31.00K
Operating Expenses
¥ 1.38B¥ 1.65B¥ 1.02B¥ 264.95M¥ 1.03B
Depreciation and Amortization
¥ 152.47M¥ 110.17M¥ 76.78M¥ 42.77M¥ 31.12M
EBITDA
¥ -223.85M¥ -670.04M¥ -744.63M¥ -198.91M¥ -972.78M
Operating Income
¥ -376.32M¥ -1.12B¥ -932.74M¥ -256.80M¥ -1.03B
Other Income/Expenses
¥ -206.56M¥ 75.67M¥ 88.28M¥ 9.53M¥ 17.61M
Pretax Income
¥ -582.88M¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B
Net Income
¥ -290.06M¥ -1.04B¥ -844.46M¥ -247.28M¥ -1.01B
Per Share Metrics
Basic EPS
¥ -0.86¥ -3.24¥ -2.70¥ -0.83¥ -3.44
Diluted EPS
¥ -0.86¥ -3.24¥ -2.70¥ -0.83¥ -3.44
Weighted Average Shares Outstanding
 336.46M 320.92M 313.06M 297.63M 293.23M
Weighted Average Shares Outstanding (Diluted)
 336.46M 320.92M 313.06M 297.63M 293.27M
Currency in CNY

Everest Medicines Ltd. Earnings and Revenue History